Use of somatostatin in the treatment of digestive fistulas. Pharmacoeconomic issues

Digestion

Volumn 60, Issue SUPPL. 3, 1999, Pages 65-70

  Fagniez, Pierre Louis ^a   Yahchouchy, Elie ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Digestive tract; Economics; Enterocutaneous pharmacology; Fistulas; Somatostatin

Indexed keywords

SOMATOSTATIN;

COST CONTROL; DIGESTIVE SYSTEM FISTULA; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; REVIEW; TOTAL PARENTERAL NUTRITION;

EID: 0032700502     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051491     Document Type: Review

References (45)

1. Levy E, Olivier JM, Masini JP, et al: Fistules entérocutanées postopératoires: Données actuelles. Encycl Méd Chir (Elsevier, Paris), Gastro-entérologie, 9-067-A-10, 1996, 16 pp.
2. Wheeler HB: Myth and reality in general surgery. Bull Am Coll Surg 1993;78:21-27.
3. Tiret L, Rotman N, Hatton F, Fagniez PL: La chirurgie digestive en France. Une enquête épidémiologique nationale. Gastroenterol Clin Biol 1988;12:354-366.
4. Kirton OC, Civetta JM, Hudson-Civetta J: Cost effectiveness in the Intensive Care Unit. Surg Clin North Am 1996;76:175-200.
5. Drucker WR, Gavett JW, Kirshner R, Messick WJ, Ingersoll G: Toward strategies for cost containment in surgical patients. Am Surg 1983; 198:284-289.
6. Sansoni B, Irving M: Small bowel fistulas. World J Surg 1985;9:897-903.
7. Soeters PB, Ebeid AM, Fischer JE: Review of 404 patients with gastrointestinal fistulas: Impact of parenteral nutrition. Ann Surg 1979; 190:189-202.
8. Berry SM, Fischer JE: Enterocutaneous fistulas. Curr Probl Surg 1994;31:471-566.
9. Edmunds LH, Williams GH, Welch CE: External fistulas arising from the gastrointestinal tract. Ann Surg 1960;152:445-471.
10. Kuvshinoff BW, Brodish RJ, McFadden DW, et al: Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal-cutaneous fistulas. Ann Surg 1993;217:615-623.
11. Schwartz RW, Barker DE, Griffen WD Jr, et al: Gastrointestinal disconnection and the treatment of intra-abdominal sepsis. Am Surg 1989; 55:50-54.
12. McIntyre PB, Ritchie JK, Hawley PR, et al: Management of enterocutaneous fistulas: A review of 132 cases. Br J Surg 1984;71:293-296.
13. Sitges-Serra A, Jaurrieta E, Sitges-Creus A: Management of enterocutaneous fistulas: The roles of parenteral nutrition and surgery. Br J Surg 1982;69:147-150.
14. Ihse I, Larsson J, Lindstrom E: Surgical management of pure pancreatic fistulas. Hepatogastroenterology 1994;41:271-275.
15. Spiliothis J, Vagenas K, Panagopoulos K, Kalfarentzos F: Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only. Br J Clin Pract 1990;44:616-618.
16. Brazeau P, Vale W, Burgus R, et al: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79.
17. Hökfelt S, Vale W, Burgus R, et al: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79.
18. Reichlin S: Somatostatin. N Engl J Med 1983; 309:1556-1563.
19. Anad BS, Doodgame R, Grahm DY: Pancreatic secretion in man: Effect of fasting, drugs, pancreatic enzymes, and somatostatin. Am J Gastroenterol 1994;89:267-270.
20. Breder CD, Yamada Y, Yasuda K, et al: Differentiel expression of somatostatin receptors subtypes in the brain. J Neurosci 1992;12:3920-3925.
21. Andrisani OM, Dixon JE: Somatostatin gene regulation. Annu Rev Physiol 1990;52:793-798.
22. Boden G, Sivitz MC, Owen OE: Somatostatin suppresses secretion and pancreatic exocrine secretion. Science 1975;190:163-165.
23. Di Costanzo J, Cano N, Martin J: Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition. Lancet 1982;7:338-339.
24. Di Costanzo J, Cano N, Martin J, Richieri JP, Mercier R, Lafille C, Lepeuch D: Treatment of external gastrointestinal fistulas by a combination of total parenteral nutrition and somatostatin. J PEN 1987;11:465-470.
25. Hild P, Dobroschke J, Henneking K: Behandlung enterokutaner Fisteln und Somatostatin. Klinikarts 1986;15:24-29.
26. von Jost JO, Clemens M, Rühland D, Bünte H: Somatostatin bei Pankreas- und Dünndarmfisteln. Zentralbl Chir 1984;109:527-531.
27. Saari A, Schröder T, Kivilaakso E, Kalima T, Lempinen M: Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition. Scand J Gastroenterol 1989;24:859-862.
28. Desport JC, Sardin B, et al: Fistules biliaires, possible intérêt de la somatostatine. Presse Méd 1986;15:2257-2259.
29. Berthet B, Delaitre P, Berdah S, Assadourian R: Traitement des fistules pancréatiques par la somatostatine. J Chir 1995;132:225-228.
30. Benke P, Cano N, Martin J: Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition. Lancet 1982;7:338-339.
31. de Gialluly M, Schröder T, Kivilaakso E, Kalima T, Lempinen M: Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition. Scand J Gastroenterol 1989;24:859-862.
32. Fagniez PL, Yahchouchy E, Allaert FA, French Study Group: Appropriate use, efficacy, and efficiency of somatostatin use in digestive fistulas. In press.
33. Pederzoli P, Bassi C, Falconi M, Albrigo R, Vantini Y, Micciolo R: Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatoslatin, glucagon or calcitonin. Surg Gynecol Obstet 1986; 163:428-432.
34. Planas M, Porta Y, Angles R, Baena JA, Serra J, Padro JB: Somatostatina y/o nutricion parenteral total en el tratamiento de las fistulas intestinales. Rev Esp Enf Digest 1990;78:345-347.
35. Torres A, Landa J, Moreno-Azcoita M, et al: Somatostatin in the management of gastrointestinal fistulas: A multicenter trial. Arch Surg 1992;127:97-100.
36. Traverso LW: Technology and surgery: Dilemma of the Gimmick, true advances, and cost effectiveness. Surg Clin North Am 1996;76: 129-138.
37. Berwick DM: Continuous improvement as an ideal in health care. N Engl J Med 1989;320: 53-58.
38. Seus JD, Wood T: Reaping maximum benefits from minimally invasive surgery. J Hlth Care Mat Management 1994;12:20-29.
39. Gill BD, Traverso LW: Continuous quality improvement: Open versus laparoscopic groin hernia repair. Surg Endosc 1993;7:116-119.
40. Fein R: On measuring economic benefits of health programs: in McLachlan G, McKeown T (eds): Medical History and Medical Care: A Symposium of Perspectives. London, Oxford University Press, 1971, pp 179-195.
41. Christoffel T: Medical care evaluation: An old new idea. J Med Educ 1976;51:83-88.
42. Codman EA: The product of a hospital. Surg Gynecol Obstet 1914;18:491-496.
43. Kirton OC, Civetta JM, Hudson-Civetta J: Cost effectiveness in the intensive care unit. Surg Clin North Am 1996;76:175-200.
44. Scholl DE, Tosch P, Wood M: Clinical nurse specialists as collaborative care managers. Nurs Management 1992;23:30-39.
45. Sprung CL, Eidelman LA, Steinberg A: Is the physician's duty to the individual patient or to society? Crit Care Med 1995;23:618-622.